Aneurysm clinical trials at UC Davis

2 research studies open to eligible people

Showing trials for

  • Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)

    open to eligible people ages 18-80

    The objective of the Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms with Surpass Elite with GUARDian Flow Diverter (GUARD) trial is to evaluate the safety and efficacy of the Surpass Elite with Guardian Flow Diverter System (FDS) in the treatment of unruptured, wide-neck saccular or fusiform, intracranial aneurysms (IAs) located on the internal carotid artery (ICA) or its branches.

    Davis, California and other locations

  • GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study

    open to eligible people ages 18 years and up

    A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.

    Sacramento, California and other locations

Our lead scientists for Aneurysm research studies include .

Last updated: